Lozada, Keeran Aziel S.
HRN: 24-14-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/13/2023
12/16/2023
IV
180mg
OD
Extended For 10 Days; PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes